background
declin
serum
concentr
seen
fall
winter
distanc
increas
equat
may
factor
season
increas
preval
influenza
viral
infect
studi
done
determin
serum
concentr
correl
incid
acut
viral
respiratori
tract
infect
methodologyfind
prospect
cohort
studi
serial
monthli
concentr
measur
fall
winter
healthi
adult
blind
natur
substanc
measur
particip
evalu
develop
acut
respiratori
tract
infect
investig
blind
concentr
incid
infect
particip
differ
concentr
vitamin
determin
one
hundr
ninetyf
enrol
particip
complet
studi
light
skin
pigment
lean
bodi
mass
supplement
vitamin
found
correl
higher
concentr
concentr
ngml
associ
signific
twofold
reduct
risk
develop
acut
respiratori
tract
infect
mark
reduct
percentag
day
ill
conclusionssignific
mainten
serum
concentr
ngml
higher
significantli
reduc
incid
acut
viral
respiratori
tract
infect
burden
ill
caus
therebi
least
fall
winter
temper
zone
find
present
studi
provid
direct
call
futur
intervent
studi
examin
efficaci
vitamin
supplement
reduc
incid
sever
specif
viral
infect
includ
influenza
gener
popul
subpopul
lower
concentr
pregnant
women
dark
skin
individu
obes
season
variat
incid
viral
respiratori
tract
infect
caus
influenza
respiratori
syncyti
viru
rhinoviru
explan
season
infect
consid
effect
environment
factor
surviv
transmiss
pathogen
well
behavior
suscept
host
indoor
crowd
commonli
thought
contribut
influenza
epidem
seen
winter
temper
zone
howev
influenza
epidem
occur
summer
crowd
workplac
gather
despit
presenc
viru
multitud
nonimmun
person
moreov
influenza
epidem
occur
simultan
latitud
across
globe
case
even
time
transport
method
allow
contact
person
mani
degre
longitud
period
week
welldocu
season
variat
vitamin
concentr
document
correl
concentr
latitud
resid
vitamin
known
effect
immun
system
product
antimicrobi
peptid
cathelicidin
macrophag
bdefensin
endotheli
cell
upregul
vitamin
peptid
may
involv
direct
inactiv
virus
vitamin
may
modul
product
cytokin
suppress
inflamm
therebi
reduc
sever
viral
pneumonia
associ
vitamin
defici
suscept
infect
respiratori
tract
suggest
mani
year
definit
proven
children
nutrit
ricket
develop
rachit
lung
due
infect
respiratori
tract
cod
liver
oil
rich
vitamin
use
treat
tuberculosi
epidemiolog
studi
suggest
correl
vitamin
concentr
incid
respiratori
infect
includ
influenza
prospect
observ
studi
follow
adult
women
men
known
vitamin
concentr
develop
acut
viral
respiratori
tract
infect
sinc
unknown
acut
infect
could
transient
alter
concentr
concentr
would
expect
declin
fall
winter
latitud
increas
equat
serial
serum
concentr
would
obtain
prospect
studi
done
temper
zone
studi
undertaken
determin
correl
incid
acut
viral
respiratori
tract
infect
serum
vitamin
concentr
measur
monthli
septemb
januari
healthi
adult
live
andor
work
near
greenwich
ct
usa
latitud
longitud
particip
sign
inform
consent
approv
greenwich
hospit
institut
review
board
healthi
adult
contact
formal
inform
present
ask
volunt
particip
studi
exclus
criteria
chronic
pulmonari
cardiac
renal
hepat
hematolog
neurolog
neuromuscular
metabol
disord
includ
diabet
mellitu
immunosuppress
pregnanc
andor
high
dose
aspirin
therapi
particip
exclud
thyroid
estrogen
replac
therapi
oral
contracept
mild
season
allergi
particip
agre
donat
one
tube
cc
blood
monthli
start
third
week
septemb
month
depend
interim
analysi
third
blood
draw
particip
unawar
natur
substanc
measur
also
understood
would
told
substanc
concentr
end
studi
data
might
benefit
health
reason
unrel
studi
particip
ask
report
evid
acut
respiratori
tract
infect
rhinorrhea
sore
throat
andor
cough
without
fever
chill
myalgia
arthralgia
case
would
evalu
without
charg
studi
site
obtain
sera
refriger
assay
within
hour
clinic
laboratori
greenwich
hospit
concentr
measur
duplic
chemiluminesc
immunoassay
liaisonh
first
concentr
drawn
septemb
monthli
thereaft
investig
site
blind
code
result
sent
offsit
investig
pdp
involv
clinic
assess
particip
report
symptom
seen
day
studi
site
one
two
boardcertifi
infecti
diseas
investig
jr
rjc
particip
interview
examin
felt
acut
respiratori
tract
infect
nasopharyng
swab
obtain
virolog
studi
bacteri
cultur
bacteri
infect
suspect
particip
kept
diari
symptom
call
everi
day
ill
review
sign
symptom
asymptomat
durat
symptom
total
ill
durat
antimicrobi
administ
record
case
report
form
monthli
visit
determin
particip
remind
everi
day
report
ill
visit
first
clinic
assess
made
infecti
diseas
investig
determin
ill
retrospect
report
particip
appear
acut
viral
respiratori
tract
infect
case
ill
diari
complet
virolog
studi
perform
monthli
visit
record
made
particip
regard
medic
herbal
supplement
vitamin
receipt
season
andor
vaccin
first
visit
skin
pigment
particip
determin
light
whiteyellow
intermedi
tanlight
brown
dark
brownblack
follow
record
age
sex
height
weight
occup
contact
inform
data
enter
secur
webaccess
onlin
databas
marvi
well
paper
case
report
form
backup
qualiti
verif
purpos
particip
present
acut
symptom
respiratori
tract
infect
nasopharyng
swab
obtain
place
viral
transport
media
remel
lenexa
ks
specimen
test
within
hour
collect
clinic
virolog
laboratori
yale
new
hospit
cytospinenhanc
direct
immunofluoresc
dfa
adenoviru
parainfluenza
type
respiratori
syncyti
viru
influenza
b
simulflour
respiratori
viru
screen
light
diagnost
temecula
ca
end
studi
dfaneg
specimen
frozen
assay
rtpcr
predomin
virus
known
circul
studi
period
either
includ
dfa
panel
rhinoviru
human
metapneumoviru
suboptom
detect
influenza
ill
particip
determin
either
bacteri
infect
eg
streptococc
pharyng
acut
viral
respiratori
tract
infect
latter
subclassifi
either
afebril
viral
respiratori
tract
infect
influenzalik
ill
ili
temperatur
cough
sore
throat
absenc
known
caus
laboratoryconfirm
viral
infect
bacteri
infect
evalu
studi
exclud
analysi
assum
overal
incid
viral
respiratori
tract
infect
popul
time
studi
laboratori
measur
coeffici
variat
serum
vitamin
call
enrol
particip
achiev
type
error
type
ii
error
odd
ratio
two
group
event
first
initi
serum
concentr
examin
respect
onset
respiratori
tract
viral
infect
seen
entir
studi
period
nonlinear
pharmacodynam
concentrationrespons
model
construct
paramet
estim
minim
log
likelihood
sever
famili
sigmoid
concentrationrespons
model
structur
relat
serum
concentr
length
time
illnessfre
surviv
evalu
includ
exponenti
extrem
valu
loglogist
lognorm
normal
weibul
function
next
three
observ
period
mean
concentr
calcul
particip
averag
concentr
particip
observ
period
mean
concentr
use
rather
concentr
extrapol
date
ill
could
assum
chang
concentr
begin
end
observ
period
necessarili
linear
concentr
assign
particip
becom
ill
particip
stratifi
two
group
presenc
absenc
infecti
event
autom
partit
analysi
determin
threshold
serum
would
best
discrimin
two
group
undertaken
period
observ
whole
studi
paramet
obtain
partit
analysi
compar
obtain
initi
concentrationrespons
curv
prepar
subsequ
surviv
analysi
done
determin
magnitud
risk
reduct
surviv
analysi
particip
experienc
event
becam
infect
assign
mean
vitamin
concentr
period
event
occur
particip
experi
event
assign
minimum
mean
concentr
taken
three
observ
period
approach
bias
studi
toward
accept
null
hypothesi
differ
event
rate
two
group
semiparametr
cox
proport
hazard
model
use
determin
particip
stratifi
high
low
vitamin
concentr
less
like
develop
acut
viral
respiratori
tract
infect
particip
complet
studi
experi
event
rightcensor
time
studi
end
tie
time
event
handl
use
breslow
likelihood
regress
paramet
cox
model
estim
maximum
likelihood
method
use
jmp
sa
cari
nc
usa
two
group
examin
analysi
differ
sex
age
skin
pigment
use
herbal
supplement
use
vitamin
use
vitamin
supplement
receipt
season
influenza
vaccin
prior
observ
period
analysi
involv
construct
nonlinear
model
relat
skin
pigment
ordin
scale
light
intermedi
dark
gender
nomin
fm
age
yr
height
weight
lb
vitamin
daili
dose
iu
observ
serum
vitamin
concentr
obtain
first
blood
draw
prefer
model
chosen
base
explanatori
vector
covari
achiev
lowest
akaik
inform
criterion
period
observ
studi
durat
incid
viral
respiratori
infect
determin
particip
concentr
partit
valu
comparison
made
confid
interv
mean
p
valu
calcul
use
bootstrap
resampl
routin
trial
matlab
mathwork
natick
us
resampl
function
packag
resampl
statist
resampl
stat
inc
arlington
va
usa
observ
made
regard
burden
ill
compar
day
viral
respiratori
ill
per
day
observ
particip
concentr
partit
valu
lastli
two
group
examin
differ
number
particip
develop
viral
infect
associ
posit
virolog
laboratori
studi
one
hundr
ninetyeight
particip
men
women
age
rang
enrol
studi
skin
pigment
light
whiteyellow
intermedi
tanlight
brown
dark
brownblack
one
particip
withdrew
studi
day
first
blood
draw
concentr
ngml
two
withdrew
second
blood
draw
first
period
mean
concentr
ng
ml
thu
follow
first
period
remaind
studi
studi
began
septemb
date
first
blood
draw
end
januari
two
day
last
blood
draw
interim
analysi
code
data
week
second
period
observ
caus
investig
decid
close
studi
fourth
blood
draw
end
third
period
four
patient
develop
bacteri
infect
streptococc
pharyng
two
bacteri
pneumonia
diverticul
none
infect
includ
analysi
acut
viral
respiratori
tract
infect
concentr
particip
consist
describ
literatur
includ
mean
rang
valu
found
differ
base
sex
skin
pigment
season
declin
tabl
result
initi
nonlinear
model
examin
effect
popul
covari
serum
vitamin
concentr
suggest
skin
pigment
vitamin
dose
bodi
mass
index
bmi
relat
serum
vitamin
concentr
measur
first
observ
period
figur
three
period
observ
entir
studi
partit
analysi
determin
vitamin
concentr
ngml
best
discrimin
group
develop
viral
infect
respiratori
tract
consist
valu
ngml
obtain
pharmacodynam
concentrationrespons
curv
base
initi
concentr
figur
result
cox
proport
hazard
model
present
figur
vitamin
concentr
ngml
approxim
halv
risk
develop
acut
viral
respiratori
tract
infect
observ
period
surviv
curv
depict
event
viral
infect
respect
particip
maintain
vitamin
concentr
ngml
entir
studi
surviv
uninfect
wherea
particip
surviv
without
infect
analys
group
concentr
ngml
ngml
delin
tabl
differ
due
ingest
herbal
supplement
vitamin
due
receipt
season
influenza
vaccin
vaccin
observ
period
particip
higher
concentr
vitamin
like
variabl
known
literatur
nonlinear
model
associ
higher
vitamin
concentr
lighter
skin
pigment
ingest
vitamin
latter
also
explain
seemingli
appar
differ
high
low
vitamin
group
base
gender
men
vitamin
supplement
took
iu
daili
number
women
studi
respect
examin
burden
ill
incid
clinic
diagnos
acut
viral
respiratori
tract
infect
percentag
day
ill
particip
concentr
ngml
ngml
determin
tabl
observ
period
entir
studi
incid
viral
respiratori
infect
percentag
day
ill
significantli
lower
group
concentr
ngml
inde
group
ngml
entir
studi
period
incid
infect
time
lower
p
percentag
day
ill
ngml
group
compar
ngml
group
time
lower
howev
precis
multipl
could
determin
proper
analysi
requir
knowledg
exact
rang
ill
durat
higher
group
discuss
could
determin
due
small
number
infect
group
obvious
unless
durat
ill
group
higher
concentr
longer
group
fold
reduct
incid
would
reduc
percentag
day
ill
least
factor
higher
group
particip
concentr
ngml
median
durat
ill
day
infect
rang
day
particip
concentr
ngml
median
durat
also
day
infect
rang
day
influenza
median
durat
high
low
group
day
infect
antivir
given
day
infect
rang
day
antivir
two
particip
respect
number
infect
particip
concentr
ngml
small
determin
differ
ill
durat
statist
signific
number
particip
mean
concentr
ngml
first
period
second
third
eighteen
particip
maintain
concentr
ngml
entir
studi
develop
viral
infect
particip
develop
infect
mean
concentr
vitamin
ng
ml
entir
studi
particip
high
vitamin
concentr
one
develop
laboratoryconfirm
viral
infect
particip
laboratoryconfirm
case
due
small
number
infect
ngml
group
studi
low
power
detect
differ
incid
laboratoryconfirm
infect
two
group
p
bootstrap
analysi
trial
studi
first
prospect
studi
correl
serum
concentr
incid
viral
respiratori
infect
adult
women
men
day
fall
winter
temper
zone
serum
concentr
ngml
higher
associ
twofold
decreas
risk
develop
acut
viral
infect
respiratori
tract
effect
size
larg
demonstr
confid
rel
small
studi
three
consecut
period
whole
studi
incid
infect
group
ngml
significantli
lower
p
valu
respect
ngml
group
analysi
base
initi
concentr
reveal
higher
concentr
greater
reduct
incid
viral
infect
respiratori
tract
effect
plateau
concentr
ngml
find
herein
may
explain
appar
lack
effect
supplement
vitamin
reduc
incid
viral
infect
respiratori
tract
studi
done
ling
et
al
placebocontrol
intervent
studi
mean
concentr
ngml
reach
treatment
group
end
studi
still
ngml
concentr
reach
ngml
studi
might
power
detect
differ
treatment
group
concentr
observ
present
studi
consist
known
pharmacolog
vitamin
human
importantli
increas
melanin
content
skin
known
block
solar
ultraviolet
b
radiat
requir
first
step
synthesi
vitamin
skin
predict
vitamin
concentr
ratio
individu
intermedi
dark
pigment
compar
lightli
pigment
individu
studi
approxim
respect
given
addit
vitamin
intak
similar
bodi
mass
index
particip
abl
maintain
concentr
ngml
entir
studi
light
skin
pigment
vitamin
supplement
data
suggest
nonlinear
respons
dose
vitamin
serum
concentr
may
relat
suggest
increas
metabol
vitamin
individu
higher
serum
vitamin
concentr
studi
also
found
invers
relationship
bodi
mass
index
serum
concentr
vitamin
consist
higher
volum
distribut
individu
higher
bodi
mass
index
due
high
fat
solubl
vitamin
number
limit
studi
first
number
ill
particip
concentr
ngml
small
determin
whether
infect
particip
statist
signific
shorter
durat
ill
subsequ
studi
requir
determin
durat
ill
caus
specif
virus
examin
light
vitamin
concentr
expect
would
mani
case
influenza
number
case
geograph
area
studi
rel
small
larg
percentag
subject
receiv
vaccin
second
period
studi
peak
time
influenza
studi
locat
virolog
studi
perform
use
multiplex
dfa
initi
screen
pcr
select
virus
test
includ
coronaviru
parainfluenza
type
nevertheless
recoveri
rate
studi
similar
rate
report
literatur
studi
respiratori
tract
viral
infect
healthi
adult
pcr
test
virus
done
howev
studi
small
number
infect
seen
particip
concentr
ngml
limit
determin
effect
incid
infect
caus
specif
virus
studi
need
result
studi
assum
appli
set
call
studi
determin
vitamin
concentr
effect
follow
incid
acut
viral
respiratori
tract
infect
individu
year
age
incid
viral
infect
affect
organ
system
time
year
cours
bacteri
mycobacteri
fungal
infect
cours
specif
infect
wors
group
prone
lower
concentr
vitamin
eg
influenza
pregnant
women
obes
tuberculosi
dark
skin
individu
fungal
infect
dark
skin
patient
addit
care
intervent
studi
would
requir
evalu
potenti
therapeut
effect
vitamin
cours
establish
infect
type
data
suggest
threshold
progress
higher
concentr
vitamin
result
benefit
reduc
incid
viral
infect
respiratori
tract
larger
studi
might
undertaken
examin
differ
rang
vitamin
concentr
ngml
monitor
longterm
benefici
advers
effect
given
widespread
presenc
vitamin
receptor
mani
cell
type
importantli
studi
demonstr
benefici
effect
serum
concentr
vitamin
ngml
slightli
higher
concentr
ngml
current
believ
repres
suffici
quit
safe
supplement
one
diet
achiev
concentr
ngml
supplement
done
diet
suffici
calcium
result
need
replic
popul
sinc
latitud
season
skin
pigment
bodi
mass
index
affect
serum
vitamin
concentr
costbenefit
supplement
without
laboratori
test
need
determin
estim
billion
peopl
worldwid
vitamin
concentr
ngml
much
larger
number
would
expect
concentr
ngml
found
particip
entir
durat
studi
averag
adult
viral
respiratori
tract
infect
year
result
countless
physician
visit
day
lost
school
work
enorm
direct
indirect
cost
studi
estim
unit
state
alon
million
noninfluenza
viral
respiratori
tract
infect
year
result
million
school
day
million
workday
miss
ill
caregiv
billion
dollar
cost
data
studi
suggest
supplement
vitamin
rais
concentr
gener
popul
ngml
could
result
signific
health
benefit
reduc
burden
ill
viral
infect
minimum
viral
infect
respiratori
tract
healthi
adult
live
temper
climat
find
may
provid
direct
call
futur
intervent
studi
examin
efficaci
vitamin
supplement
reduc
incid
sever
specif
viral
infect
includ
influenza
gener
popul
specif
subpopul
pregnant
women
dark
skin
individu
obes
